Name | NR2F1 agonist 1 |
---|
Description | NR2F1 agonist 1, a nuclear receptor NR2F1 agonist, specifically activates dormancy programs in malignant cells. NR2F1 agonist 1 up-regulates NR2F1 and downstream target genes that regulate dormancy. NR2F1 agonist 1 induces neural crest-like and growth suppression in head and neck squamous cell carcinoma (HNSCC) via NR2F1 activation. NR2F1 agonist 1 inhibits tumor growth in a mouse primary tumor model[1]. |
---|---|
Related Catalog | |
In Vitro | NR2F1 agonist 1(化合物 C26)(0.5 μM,1 μM;18 小时)显着诱导 D-HEp3 细胞中的荧光素酶表达[1]。 NR2F1 agonist 1(0.5 μM;7 天)显着下调磷酸肌醇 3-激酶 (PI3K) 信号通路[1]。 NR2F1 agonist 1(0.5 μM;7 天)显着上调 SOX9、RARβ 和 p27 的 mRNA 水平[1]。 NR2F1 agonist 1(0.5 μM;48 小时)在 D-HEp3 细胞中诱导细胞周期停滞在 G0/G1 期[1]。 |
In Vivo | NR2F1 agonist 1(0.5 mg/kg/天;腹腔注射;3 周)抑制小鼠模型肺部的原发性肿瘤生长和转移性生长[1]。 Animal Model: BALB/c nu/nu mice bearing GFP-tagged T-HEp3 PDX cells[1] Dosage: 0.5 mg/kg/day Administration: Intraperitoneal injection; injected for 3 weeks or for 1 week followed by DMSO for 2 weeks Result: Did not induce apoptosis of proliferating primary tumor cells, but exhibited metastasis inhibitory effect against T-HEp3 cells. |
References |
Molecular Formula | C28H30N4OS |
---|---|
Molecular Weight | 470.63 |